This pilot study will have patients use a smart sharps disposal container at home for disposal of needles used to administer their hemophilia drugs. The study aims to find out if the smart sharps container proved acceptable to use by patients and medical providers and can be adhered to.
Preventative factor or non-factor product IV administration has been shown to improve outcomes in patients with hemophilia. The need for patients to log their doses or complete questionnaires can be burdensome. This study seeks to use novel technology, a smart sharps container that records disposal of the needle used to administer preventive products. We will perform a prospective study of adult patients with hemophilia A/B who are on factor or non-factor products. They will all be given the device to take home and use there.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
23
The smart Sharps device is given to the patient and they use it to throw needles away in. It is not internal to the patient.
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Penn Blood Disorders Program
Philadelphia, Pennsylvania, United States
Adherence
% from baseline to active phase that patient adheres to using needle disposal
Time frame: Days 1-180
Patient and provider satisfaction survey
Patient and provider satisfaction survey
Time frame: Day 181 +/- 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.